Fulgent Genetics (FLGT)
(Delayed Data from NSDQ)
$21.41 USD
-0.27 (-1.25%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $21.40 -0.01 (-0.05%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth B Momentum B VGM
Industry / Sector Report
Industry : Medical Info Systems
Zacks Industry Rank
Top 26% (66 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.67 | 1.81 | 9.99 |
Current Quarter Estimate | -0.19 | 0.16 | 61.00 |
Year Ago Quarter Estimate | -0.39 | -0.50 | 54.84 |
Next Quarter Estimate | -0.40 | 0.36 | 63.00 |
Next Year Estimate | -0.63 | 1.25 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -7.32 | 22.30 | 15.67 |
Next Year | -43.18 | 24.10 | 11.34 |
Last 5 Years | -228.10 | -10.70 | 8.10 |
Next 5 Years | NA | 18.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 722.67 | 21.67 |
Price/Book (MRQ) | 0.58 | 1.33 |
Price/Cash Flow (MRFY) | 6.67 | 6.80 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -56.22% | -48.54% |
Return on Equity (TTM) | -2.75% | -43.61% |
Debt to Equity (MRQ) | 0.00 | 2.90 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.